# Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients

> **NCT02455271** · — · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 438 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Eszopiclone

## Key facts

- **NCT ID:** NCT02455271
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-01
- **Primary completion:** 2015-03-30
- **Final completion:** 2015-12-22
- **Target enrollment:** 438 (ACTUAL)
- **Last updated:** 2018-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455271, "Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02455271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*